51. Indocyanine Green Conjugated Phototheranostic Nanoparticle for Photobiomodulation
- Author
-
Hisahiro Matsubara, Akiko Suganami, Yutaka Tamura, Tsutomu Tanaka, Kazuoki Isojima, Yoko Shinozaki, Kengo Saito, Yasushi Miyauchi, Toshinori Nakayama, Naohito Nakamura, Kenta Shinoda, Yasumitsu Moriya, Hiroshi Suito, Masamichi Yamashita, Akane S. Suzuki, Hiroshi Shirasawa, Yasunori Akutsu, and Yoshiharu Okamoto
- Subjects
History ,Polymers and Plastics ,Tumor region ,medicine.medical_treatment ,Cancer ,Nanoparticle ,Conjugated system ,medicine.disease ,Industrial and Manufacturing Engineering ,chemistry.chemical_compound ,chemistry ,Cancer immunotherapy ,In vivo ,medicine ,Cancer research ,Tumor necrosis factor alpha ,Business and International Management ,Indocyanine green - Abstract
Phototheranostics represents a highly promising paradigm for cancer therapy, although selecting an appropriate optical imager for clinical use remains challenging. We evaluated the phototheranostic nanoparticle-related properties of liposomally formulated phospholipid-conjugated indocyanine green, denoted as LP-iDOPE, for cancer diagnosis and treatment using photobiomodulation with a near-infrared (NIR)-light emitting diode (LED) light irradiator. Using in vivo NIR fluorescence imaging, we demonstrated that LP-iDOPE was selectively delivered to tumor sites with high accumulation and a long half-life. Following NIR-LED light irradiation of the tumor region of LP-iDOPE accumulation, effector CD8+ T cells were activated at the secondary lymphoid organs, migrated, and subsequently released cytokines including interferon-γ and tumor necrosis factor-α, resulting in effective tumor regression. Our cancer immunotherapy strategy using LP-iDOPE as a phototheranostic nanoparticle and an NIR-LED light irradiator as a photobiomodulation device represents a promising approach to noninvasive cancer therapy.
- Published
- 2020